Search Results for 'bleeding vte'
bleeding vte published presentations and documents on DocSlides.
EMBOLI Dr H Objectives General VTE guidelines
by oneill
Special Situations. Atrial Thrombus Treatment Opti...
New (Direct)Oral anti-coagulants in the treatment of VTE
by ariel
Dr NA Smith - Haematology Dept. Heart of England...
Challenging Case Study: VTE Treatment- “How Long is Long Enough?”
by olivia-moreira
Thomas W. Butler, M.D., F.A.C.P.. Associate Profe...
EINSTEIN DVT and EINSTEIN PE Pooled Analysis
by olivia-moreira
'Xarelto' for the Treatment of Symptomatic Venous...
Outpatient DVT assessment & treatment
by marina-yarberry
Daniel Gilada. Prevalence. ~1 million cases a yea...
Common Conundrums in Venous Thromboembolism
by alexa-scheidler
Brandon . McMahon,. MD. Venous . Thromboembolism...
New Strategies to Prevent CV Events After Hospital Discharge
by luanne-stotts
Program Agenda. Crisis and Unmet Needs in Medical...
Optimal Management of Anticoagulation Therapy
by mia
An Educational Slide Set . American Society of Hem...
Anticoagulant Options for the Management of Acute Cancer-Associated Thrombosis
by collectmcdonalds
Presented by. Faculty/Presenter Disclosure. Facult...
Treatment of Venous Thromboembolism: Thrombophilia Testing
by phoebe
An Educational Slide Set . American Society of Hem...
Selecting Direct Oral Anticoagulants and Reversal Agents
by tremblay
Geno J . Merli. , MD, MACP, FSVM, FHM. Professor M...
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
Judicious Use of Anticoagulation: A Case-Based Approach
by sherrill-nordquist
Judicious Use of Anticoagulation: A Case-Based Ap...
Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial
by natalia-silvester
Sponsored by Bristol-Myers Squibb and Pfizer. Sam...
Aspirin for Preventing the Recurrence of Venous
by liane-varnes
Thromboembolism. N . Engl. J Med. 2012;366:1959-...
Update on the New Oral Anticoagulants
by sherrill-nordquist
Eliot Williams, MD PhD. Division of Hematology &a...
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
The EINSTEIN EXT Study 'Xarelto' for
by tatiana-dople
the . Long-Term Prevention of Recurrent Venous Th...
Hematological Issues in Pregnancy
by natalia-silvester
Ernest Quintin, PGY V. LSU New Orleans Hematology...
COAGULATION Dr. Hasan Fahmawi, MRCP(UK), FRCP(
by DoctorNerdLove
Edin. ). Haemostasis-blood must be maintained in a...
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
Prevention of venous thromboembolism in surgical patients, medical patients and long-distance trave
by joy
Educational Slide Kit . American Society of Hemato...
Optimal Management of Anticoagulant Therapy
by harper
Educational Slides Set. American Society of Hemato...
Manchester Menopause Draft Guidelines
by KissableLips
&. Case discussions . Dr Manju . Navani. June...
Objectives At the end of this talk you will be able to:
by Heartstealer
Describe the rationale for extended duration (30 d...
The thick and thin of it: Reviewing Anticoagulant Options
by oneill
Lanae Fox, . PharmD. , BCPS. I have no financial d...
Antithrombotic therapy and oral surgery
by debby-jeon
Antithrombotic therapy and oral surgery Michael B...
Non-vitamin K antagonist oral anticoagulants
by tawny-fly
(NOACs) . YOUR FACILITY. Presenter. Month YYYY. S...
Unprovoked DVT in a young patient
by lois-ondreau
Cecile du Toit. Groote . Schuur. Hospital + UCT....
Rivaroxaban compared with enoxaparin for the prevention of
by luanne-stotts
Alexander T Cohen . On behalf of the MAGELLAN Ste...